Longer follow-up confirms major improvement in outcome in children and adolescents with Philadelphia chromosome acute lymphoblastic leukaemia treated with continuous imatinib and haematopoietic stem cell transplantation. Results from the Spanish Cooperative Study SHOP/ALL-2005

Br J Haematol. 2013 Aug;162(3):419-21. doi: 10.1111/bjh.12373. Epub 2013 May 14.
No abstract available

Keywords: Philadelphia chromosome; acute lymphoblastic leukaemia; children; imatinib; tyrosine kinase inhibitor.

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Antineoplastic Agents / administration & dosage*
  • Benzamides / administration & dosage*
  • Child
  • Drug Administration Schedule
  • Follow-Up Studies
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Imatinib Mesylate
  • Piperazines / administration & dosage*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Pyrimidines / administration & dosage*
  • Survival Analysis
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate